Austrian Left Atrial Appendage Closure Registry
Recruiting · NCT03409159 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medical University of Graz
View the official record on ClinicalTrials.gov →Interventions studied
LAAC
What this trial is about
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients who received LAAC in Austria
Exclusion criteria
- Absence of informed consent
Where it is running
1 location listed.
- Medical University of Graz - Graz, Austria